
Epidemiologist - Cardiovascular @BayerPharma
Berlin, Germany
Joined June 2009
- Tweets172
- Following125
- Followers47
- Likes243
See our new publication on the importance of Understanding Causes of Death in Patients With ARDS journals.lww.com/ccejournal/…
11
Great to see the impact of our work on Pulmonary thromboembolic events in COVID-19 which was published in Pulmonary Circulation is now one of their top 10 most-cited papers for 2022-23!
doi.org/10.1002/pul2.12113
1
18
Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: A descriptive study
journals.sagepub.com/doi/10.…
16
See our new publication of study design of a prospective study on persistence and adherence. sciencedirect.com/science/ar…
1
25
See our recent publication summarizing the global epidemiology of gastrointestinal bleeding in general population
wjgnet.com/1948-9366/full/v1…
25
Pareen Vora retweeted
Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study - https://nitter.cf/t.co/BCKa0zROD4
Read our publication on CardioAspirin and Gastrointestinal Cancer prevention in Hong Kong bmjopen.bmj.com/content/12/2…
Read our publication on Oral Anticoagulants utilization trends in 5 countries and 9 data sources using #TreatmentPathway tool and #ATLAS #OHDSI #OMOP #CDM #LargeScaleAnalytics #DataVisualization hindawi.com/journals/ijclp/2… via @Hindawi
Gender Stereotypes | Zoe Cash | TEDxYouth@BerlinCosmopolitanSchool youtu.be/SCwqQcExWqY via @YouTube
Read our publication on the public health impact of low-dose aspirin! sciencedirect.com/science/ar…
Read more about our study published as open access in The Patient - Patient Centered Outcomes Research.
link.springer.com/article/10…
1
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network onlinelibrary.wiley.com/doi/…
Thirty-Year Incidence and Mortality Trends in Gastrointestinal Bleeding in Finland ja.ma/3iXYxXG via @JAMANetworkOpen part of @JAMANetwork
Pareen Vora retweeted
1/ We don't have a vaccine yet, but we have a treatment that may reduce the risk of #COVID19 by 20% without serious side effects.
That treatment is #hydroxychloroquine.
Risk ratio of COVID-19 in our meta-analysis of 3 prophylaxis randomized trials: 0.78
medrxiv.org/content/10.1101/…
Pareen Vora retweeted
4/ Update #1
The findings from a fourth randomized trial were published today. They change neither the risk ratio estimate nor our conclusion:
We need additional randomized trials to obtain a more precise estimate of the effect of #hydroxychloroquine, overall and in subgroups.
Pareen Vora retweeted
#Clinicaltrials rebound after COVID-19 crash, but can enrollment gains continue? sciencemag.org/news/2020/07/… @pareenvora @SuzartK @alexhabs @mrpusch – at Berlin, Germany
Pareen Vora retweeted
My #coronavirus #COVID19 test finally arrived 3 MONTHS after I ordered it. I hope it works. 10 tests are in. Will show results to my friends at the #MITCOVID18CHALLENGE , @FariqRed , and @Bayer .
Pareen Vora retweeted
Replying to @AmberTongPW







